To provide further additional continuing appropriations for fiscal year 2019, and for other purposes.
Latest action. Referred to the Committee on appropriationA law permitting federal agencies to spend money. The Constitution forbids any spending without one, Congress's 'power of the purse'.Read the full definition (opens a new tab), and in addition to the Committee on the Budget, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdictionA court's legal authority to hear a case: over the subject matter, the parties, and the territory.Read the full definition (opens a new tab) of the committee concerned.
DIVISION A--FURTHER ADDITIONAL CONTINUING APPROPRIATIONS ACT, 2019
Further Additional Continuing Appropriations Act, 2019
(Sec. 101) This division amends the Continuing Appropriations Act, 2019 to provide continuing FY2019 appropriations to several federal agencies through the earlier of February 8, 2019 (December 21, 2018, under current law), or the enactment of the applicable appropriations legislation.
It is known as a continuing resolution (CR) and ends the partial government shutdown that began when the existing CR expired because seven of the remaining FY2019 appropriations bills have not been enacted.
(Five of the FY2019 appropriations bills were enacted earlier this year, including:
the Department of Defense Appropriations Act, 2019;
the Energy and Water Development and Related Agencies Appropriations Act, 2019;
the Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2019;
the Legislative Branch Appropriations Act, 2019; and
the Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2019.)
The CR extends through February 8, 2019:
the Department of Homeland Security Chemical Facility Anti-Terrorism Standards Program;
the authority for the Department of Health and Human Services Biomedical Advanced Research and Development Authority to withhold from public disclosure certain technical data or scientific information that reveals vulnerabilities of existing medical or public health defenses against biological, chemical, nuclear, or radiological threats; and
an exemption from antitrust laws for meetings and consultations to discuss the development of certain vaccines and drugs related to public health threats such as bioterrorism, pandemics, or epidemics.
Additionally, the CR has the effect of extending through February 8, 2019, several authorities and programs that were extended in prior CRs, including:
the National Flood Insurance Program,
the Violence Against Women Act,
the authority for the Environmental Protection Agency to collect and spend certain fees related to pesticides,
the Temporary Assistance for Needy Families (TANF) program, and
several authorities related to immigration.
The CR also delays the release of required Congressional Budget Office and Office of Management and Budget sequestration reports.
The summary continues for 7 more paragraphs. Read it in full on Congress.gov
Written by analysts at the Congressional Research Service and published on Congress.gov, not by Civibrief. Summarized at the "Introduced in House" stage on December 22, 2018. It describes the bill, it is not the legal text.
Where is it in the process, and what happens next?
4 steps remain before this bill could become law.
The record's latest action, on December 22, 2018: Referred to the Committee on Appropriations, and in addition to the Committee on the Budget, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- Clearing the committees it was referred to, and being scheduled for a floor vote
- Passage by the House
- Passage by the Senate
- The President's signature. If the President vetoes it, two-thirds of both chambers must vote to override.
How likely is it to become law?
Civibrief does not forecast outcomes and this page has no opinion about this one. What the record supports is a base rate, which is a fact about the whole pile, not a prediction about this measure.
In the 115th Congress (2017-18), 442 of the 11,421 bills and joint resolutions introduced became law, about 3.9 percent. That count covers every measure at every stage, including the many that never left committee.
This one is not there yet: 4 steps are still outstanding, listed above.
Has anyone actually voted on it?
No. No roll call in this Congress cites this measure. That is the ordinary outcome: most measures never reach a recorded floor vote, and a committee ends most of them simply by not acting.
A vote is not the only thing that happens to a measure. Hearings, markups, and referrals are all recorded actions, and none of them is a vote of the full chamber.
Who is behind it?
STENY HOYER (D-MD) introduced it on December 22, 2018. No cosponsors are recorded.
Cosponsoring is a formal signature on the text. It is not a commitment to vote for the measure, it does not bind anyone's party, and a long list of cosponsors is a measure of attention rather than of prospects.
How long has it been in play?
It was introduced on December 22, 2018, 2819 days ago. The most recent recorded action was 2819 days ago, on December 22, 2018.
Measures do not carry over. Anything the 115th Congress has not finished by January 3, 2019 dies when the term ends, and has to be introduced again from the start in the next Congress.
Every answer above is assembled from this measure's own record on Congress.gov and from published counts of what Congress has passed before. Civibrief does not predict outcomes and takes no position on any measure.
Vote history
- HouseIn committee, no floor vote yet
- SenateAwaits House passage
- PresidentAwaits both chambers